GSK

GSK · LONDON

$50.75−$0.46 (−0.90%)TodayMarket closed · Oct 23, 7:59 PM ET

Prev close $51.21

GSK analyst rating

HoldConsensus of 3 analysts over the last 12 months. 33% rate it a buy.

Strong buy0
Buy1
Hold1
Underperform1
Sell0

12-month price target · 25 analysts

Average $59.66 (+17.6% upside)

Low: $39.35
Now: $50.75
High: $84.63

Upgrades and downgrades

The latest rating actions, newest first

GSK analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Hit rate
Citigroup	Jul 24, 2026	Initiates	Neutral	0%
Barclays	Jan 6, 2026	Downgrade	Equal-Weight → Underweight	89%
Jefferies	Oct 27, 2025	Initiates	Hold → Buy	80%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.